Patents Assigned to Wellstat Therapertics Corporation
  • Compound for the treatment of metabolic disorders
    Patent number: 8487000
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: July 16, 2013
    Assignee: Wellstat Therapertics Corporation
    Inventors: Shalini Sharma, Reid W. von Borstel